Faron Pharmaceuticals (UK) Probability of Future Stock Price Finishing Under 142.5
| FARN Stock | 170.00 5.00 3.03% |
Faron |
Faron Pharmaceuticals Target Price Odds to finish below 142.5
The tendency of Faron Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to 142.50 or more in 90 days |
| 170.00 | 90 days | 142.50 | about 6.15 |
Based on a normal probability distribution, the odds of Faron Pharmaceuticals to drop to 142.50 or more in 90 days from now is about 6.15 (This Faron Pharmaceuticals Oy probability density function shows the probability of Faron Stock to fall within a particular range of prices over 90 days) . Probability of Faron Pharmaceuticals price to stay between 142.50 and its current price of 170.0 at the end of the 90-day period is about 25.37 .
Assuming the 90 days trading horizon Faron Pharmaceuticals has a beta of 0.46. This usually indicates as returns on the market go up, Faron Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Faron Pharmaceuticals Oy will be expected to be much smaller as well. Additionally Faron Pharmaceuticals Oy has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Faron Pharmaceuticals Price Density |
| Price |
Predictive Modules for Faron Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Faron Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Faron Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Faron Pharmaceuticals is not an exception. The market had few large corrections towards the Faron Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Faron Pharmaceuticals Oy, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Faron Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.28 | |
β | Beta against Dow Jones | 0.46 | |
σ | Overall volatility | 25.96 | |
Ir | Information ratio | -0.08 |
Faron Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Faron Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Faron Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Faron Pharmaceuticals generated a negative expected return over the last 90 days | |
| Faron Pharmaceuticals has high historical volatility and very poor performance | |
| Net Loss for the year was (30.94 M) with profit before overhead, payroll, taxes, and interest of 803 K. | |
| Faron Pharmaceuticals generates negative cash flow from operations | |
| About 32.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: BofA upgrades Ametek stock to buy, raises target - Investing.com |
Faron Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Faron Stock often depends not only on the future outlook of the current and potential Faron Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Faron Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 68.8 K | |
| Cash And Short Term Investments | 6.9 M |
Faron Pharmaceuticals Technical Analysis
Faron Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Faron Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Faron Pharmaceuticals Oy. In general, you should focus on analyzing Faron Stock price patterns and their correlations with different microeconomic environments and drivers.
Faron Pharmaceuticals Predictive Forecast Models
Faron Pharmaceuticals' time-series forecasting models is one of many Faron Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Faron Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Faron Pharmaceuticals
Checking the ongoing alerts about Faron Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Faron Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Faron Pharmaceuticals generated a negative expected return over the last 90 days | |
| Faron Pharmaceuticals has high historical volatility and very poor performance | |
| Net Loss for the year was (30.94 M) with profit before overhead, payroll, taxes, and interest of 803 K. | |
| Faron Pharmaceuticals generates negative cash flow from operations | |
| About 32.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: BofA upgrades Ametek stock to buy, raises target - Investing.com |
Additional Tools for Faron Stock Analysis
When running Faron Pharmaceuticals' price analysis, check to measure Faron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Faron Pharmaceuticals is operating at the current time. Most of Faron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Faron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Faron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Faron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.